Company Filing History:
Years Active: 2019
Title: The Innovations of Bert Koops
Introduction
Bert Koops, an innovative inventor based in Pijnacker, NL, has made noteworthy contributions to the field of biotechnology. With a robust focus on enzyme engineering, Bert has developed a patented variant of the GH10 xylanase enzyme, showcasing his dedication to advancing nutritional sciences.
Latest Patents
Bert Koops holds a patent for a GH10 family xylanase variant, which demonstrates increased thermostability compared to its parent GH10 xylanase enzyme. This variant retains at least 90% sequence identity with the amino acid sequence of SEQ ID No. 1 and has been modified at two or more of specific positions numbered 7, 33, 79, 217, and 298. This innovative approach to enzyme stability is crucial for various applications in the food and nutrition industry.
Career Highlights
Currently, Bert Koops is associated with DuPont Nutrition Biosciences Aps, where he leverages his expertise in enzyme development. His work not only contributes to the company’s advancements but also paves the way for further research in enzyme applications and their benefits in nutritional products.
Collaborations
Bert collaborates with talented colleagues such as Rikke Hoeegh Lorentsen and Susan Arent Lund. These partnerships foster a creative environment that stimulates innovation and enhances research outcomes within their field.
Conclusion
Bert Koops stands out as a remarkable inventor in the realm of biotechnology. His cutting-edge work on the GH10 xylanase variant highlights the importance of innovation in enzyme research and its potential applications in improving food and nutrition products. Through his career at DuPont Nutrition Biosciences Aps and his collaborative efforts, Bert continues to contribute significantly to advancements in the industry.